| Preclinical | Phase 1 | Phase 2 | Phase 3 | |
| Major Depressive Disorder-Adjunctive Therapy | ||||
| Pediatric Indications | ||||
| Long-Acting Injectable Program |
The safety and efficacy of investigational agents and/or investigational uses of approved products have not been established.